
    
      Randomized controlled trial for safety of a 6-hour escalating dose of S-nitrosylation therapy
      or placebo to ventilated patients. This will be a single-site study conducted within the
      UH-CMC medical ICU designated COVID-19 quarantine areas.
    
  